Author

S. Biering

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Mikhailova· 1 shared A. Sakuntabhai· 1 shared B. Raynal· 1 shared C. Dugast-Darzacq· 1 shared C. Tamietti· 1 shared E. Harris· 1 shared E. Van Dis· 1 shared E. Wehri· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Mikhailova

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The dengue virus NS1 protein conveys pro-inflammatory signals by docking onto human high-density lipoproteins

S. Benfrid, K.-H. P. Park, M. Dellarole, J. E. Voss, C. Tamietti, G. Pehau-Arnaudet, B. Raynal, S. Brule, P. England, X. Zhang, A. Mikhailova, M.-N. Ungeheuer, S. Petres, S. Biering, E. Harris, , M. Flamand

This study identifies NS1-dengue virus protein's interaction with human HDL as a mechanism to trigger pro-inflammatory signals during infection.

bioRxiv · May 5, 2021Microbiology

Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells

X. Nguyenla, E. Wehri, E. Van Dis, S. Biering, L. H. Yamashiro, J. Stroumza, C. Dugast-Darzacq, T. Graham, S. Stanley, J. Schaletzky

This study identifies 20 approved drugs that synergize with remdesivir to inhibit SARS-CoV-2 replication in human lung cells, with HCV NS5A inhibitors showing the strongest effects.

bioRxiv · Sep 18, 2020Microbiology